サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463661

欧州の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別

Europe Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

出版日
ページ情報
英文 93 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.05円
欧州の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別
出版日: 2024年01月19日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の脳脊髄液管理市場は、2022年に5億4,431万米ドルと評価され、2030年には8億1,712万米ドルに達すると予測され、2022年から2030年までのCAGRは5.2%で成長すると予測されています。

CSF管理分野の研究開発が欧州の脳脊髄液管理市場を促進

この地域における髄液管理分野の研究開発は、医学知識の向上、患者の転帰の改善、治療方法の強化に取り組んでいることが特徴です。欧州諸国はヘルスケアの研究とイノベーションに積極的に投資していることで知られており、髄液管理分野に大きく貢献しています。例えば、研究機関と大学は、水頭症などの治療において極めて重要な髄液シャントシステムの改善を目的としたプロジェクトで協力しています。こうした共同研究の結果、合併症を減らし、患者の生活の質を向上させる革新的な設計、材料、低侵襲技術が生み出されることも多いです。

さらに、欧州は髄液関連疾患に関する臨床試験の最前線にあります。これらの臨床試験は、特発性頭蓋内圧亢進症（IIH）や正常圧水頭症（NPH）などの疾患に対する新しい診断ツールや治療法の開発に重点を置いています。例えば、現在進行中のNPHの診断基準や治療法の研究は、患者の標準治療を形成するものです。さらに、バイオマーカー研究は、脳脊髄液分析による診断能力を向上させています。これらのイニシアチブは、この地域が髄液管理の進展に注力していることを表しています。そのため、今後数年間は市場の成長を後押しすると予想されます。

欧州の脳脊髄液管理市場の概要

欧州の脳脊髄液管理市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツや英国などの国々は、この地域の市場に対する最大の貢献者になると予想されます。脳脊髄液減少症や悪性中枢神経系腫瘍の有病率の上昇が、欧州における同市場の成長を促す主な要因です。

欧州の脳脊髄液管理市場の収益と2030年までの予測（US$Mn）

欧州の脳脊髄液管理市場のセグメンテーション

欧州の脳脊髄液管理市場は、製品、エンドユーザー、国に区分されます。

製品別では、欧州の脳脊髄液管理市場はCSFシャントとCSFドレナージシステムに二分されます。2022年にはCSFシャントセグメントが大きな市場シェアを占めています。

エンドユーザー別に見ると、欧州の脳脊髄液管理市場は病院、クリニック、外来手術センター、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州の脳脊髄液管理市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州の脳脊髄液管理市場シェアはドイツが独占。

Argi Group Health Services Ltd Sti、B. Braun SE、Delta Surgical Ltd、Integra LifeSciences Holdings Corp、Medtronic Plc、Moller Medical GmbH、Natus Medical Inc、Sophysa SA、Spiegelberg GmbH &Co KGは、欧州の脳脊髄液管理市場で事業を展開する大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の脳脊髄液管理市場情勢

  • 欧州PEST分析

第5章 欧州の脳脊髄液管理市場-主要産業力学

  • 市場促進要因
    • 脳脊髄液漏出症例の増加
    • 髄液管理分野における研究開発
  • 市場抑制要因
    • 故障や誤作動のリスク
  • 市場機会
    • 神経疾患治療における髄液管理への注目の高まり
  • 今後の動向
    • スマート脳脊髄液シャントの開発
  • インパクト分析

第6章 脳脊髄液管理市場-欧州市場分析

  • 欧州の脳脊髄液管理市場の売上高、2022年～2030年

第7章 欧州の脳脊髄液管理市場 - 収益と2030年までの予測：製品別

  • 市場収益シェア、2022年および2030年
  • 髄液シャント
  • 髄液ドレナージシステム

第8章 欧州の脳脊髄液管理市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 診療所
  • 外来手術センター
  • その他

第9章 欧州の脳脊髄液管理市場：国別分析

  • 欧州の脳脊髄液管理市場：国別
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第10章 欧州の脳脊髄液管理市場：業界情勢

  • 欧州の脳脊髄液管理市場における成長戦略、2020-2023年
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Argi Group Health Services Ltd Sti
  • Sophysa SA
  • Delta Surgical Ltd
  • Moller Medical GmbH
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第12章 付録

図表

List Of Tables

  • Table 1. Europe Cerebrospinal Fluid Management Market Segmentation
  • Table 2. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 16. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 17. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 18. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 19. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 20. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 21. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 22. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 23. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 24. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 25. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Recent Inorganic Growth Strategies in the Europe Cerebrospinal Fluid Management Market
  • Table 27. Recent Organic Growth Strategies in The Europe Cerebrospinal Fluid Management Market
  • Table 28. Glossary of Terms, Europe Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. Europe Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. Europe Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Europe Cerebrospinal Fluid Management Market, By Key Country- Revenue (2022) ($Mn)
  • Figure 22. Europe Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies in The Europe Cerebrospinal Fluid Management Market, 2020-2023
目次
Product Code: TIPRE00028012

The Europe cerebrospinal fluid management market was valued at US$ 544.31 million in 2022 and is expected to reach US$ 817.12 million by 2030; it is estimated to grow at a CAGR of 5.2% from 2022 to 2030.

R&D in the Field of CSF Management Fuels the Europe Cerebrospinal Fluid Management Market

R&D in the field of CSF management in the region is marked by a commitment to advancing medical knowledge, improving patient outcomes, and enhancing treatment modalities. European countries are renowned for their robust investments in healthcare research and innovation, making significant contributions to the field of CSF management. For example, research institutions and universities collaborate on projects aimed at improving CSF shunt systems, which are pivotal in the treatment of conditions like hydrocephalus. These collaborations often result in innovative designs, materials, and minimally invasive techniques that reduce complications and improve patient quality of life.

Furthermore, Europe is at the forefront of clinical trials related to CSF-related disorders. These trials focus on the development of novel diagnostic tools and treatments for conditions such as idiopathic intracranial hypertension (IIH) or normal pressure hydrocephalus (NPH). For instance, the ongoing research into the diagnostic criteria and treatment options for NPH is shaping the standard of care for patients. Additionally, biomarker research is advancing the ability to diagnose through cerebrospinal fluid analysis. These initiatives represent the region's focus on advancing CSF management. Thus, it is expected to bolster the growth of the market during the coming years.

Europe Cerebrospinal Fluid Management Market Overview

The Europe cerebrospinal fluid management market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of iNPH and malignant CNS tumors are the major factors driving the growth of this market in Europe.

Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Europe Cerebrospinal Fluid Management Market Segmentation

The Europe cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Europe cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Europe cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe cerebrospinal fluid management market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cerebrospinal fluid management market share in 2022.

Argi Group Health Services Ltd Sti, B. Braun SE, Delta Surgical Ltd, Integra LifeSciences Holdings Corp, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Europe cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 R&D in the Field of CSF Management
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Europe Market Analysis

  • 6.1 Europe Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 Europe Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 UK
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 UK: Europe Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 UK: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 UK: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 UK: Europe Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Germany
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Germany: Europe Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Germany: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Germany: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Germany: Europe Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 France
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 France: Europe Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 France: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 France: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 France: Europe Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.5 Italy
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 Italy: Europe Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.5.3.1 Italy: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.5.3.2 Italy: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.5.4 Italy: Europe Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.6 Spain
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 Spain: Europe Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.6.3.1 Spain: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.6.3.2 Spain: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.6.4 Spain: Europe Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.7 Rest of Europe
        • 9.1.1.7.1 Overview
        • 9.1.1.7.2 Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.3 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.7.3.1 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.7.3.2 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.7.4 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by End User

10. Europe Cerebrospinal Fluid Management Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The Europe Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Argi Group Health Services Ltd Sti
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Sophysa SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Delta Surgical Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Moller Medical GmbH
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Natus Medical Inc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Spiegelberg GmbH & Co KG
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms